Food News and Research

RSS

Bangalore INDIA BIO 2010 inaugurated

Bangalore INDIA BIO 2010, India's premier Biotechnology event organized by the Department of Information Technology, Biotechnology and Science & Technology, Government of Karnataka, Vision Group on Biotechnology and MM Activ Sci-Tech Communications Co was inaugurated today by Shri B.S. Yeddyurappa, Hon'ble Chief Minister of Karnataka, and Shri Katta Subramanya Naidu - Hon'ble Minister for IT & BT, Information, Excise and BWSSB, Government of Karnataka.

2 Jun 2010

Perrigo acquires rights to Novel Laboratories' pending ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep Kit

Perrigo Company announced on May 26, 2010 that it had acquired rights to Novel Laboratories' pending ANDA for HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets).

2 Jun 2010

Biomoda, Obio sign MOU to establish CLIA-certified clinical laboratory in Ohio

Cancer diagnostics company Biomoda, Inc. and Obio, a corporation formed to pursue public and private funding for cancer research in Ohio, signed a memorandum of understanding to establish a CLIA-certified Biomoda clinical laboratory in Ohio to support ongoing research and development on Biomoda's porphyrin-based assay for the detection of early-stage cancer.

2 Jun 2010

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

Geisinger Medical Center will participate in ProTECT III, a groundbreaking National Institute of Health -sponsored research study for the emergency treatment of traumatic brain injuries using the hormone progesterone.

2 Jun 2010

CookShop nutrition education program helps students make healthier food choices: Survey

Hundreds of New York City public elementary school teachers reported in a survey that their students are making healthier food choices because of CookShop, a nutrition education program of the Food Bank For New York City that is funded and supported by the USDA. This finding is significant at a time when 43 percent of the city's elementary school children are overweight or obese.

2 Jun 2010

Neuro Kinetics renews independent sales representation relationship with Kwangwoo Medix

Neuro Kinetics, Inc., manufacturers of noninvasive medical diagnostic equipment used worldwide to test for vestibular and neurological dysfunctions, said today that it has renewed its independent sales representation relationship with Kwangwoo Medix, Inc., a leading Korean specialty medical device distributor.

2 Jun 2010

Health Canada releases survey results of BPA exposure levels in canned foods

As part of its research commitment on bisphenol A, Health Canada released today the results of a new survey of BPA exposure levels in a variety of canned foods. The results from this latest government survey provide confirmation that foods packaged in BPA epoxy resin coated metal cans do not pose a health risk.

2 Jun 2010

Faith-based organizations can play important role in response to HIV/AIDS in Central America: RAND study

Faith-based organizations such as churches and religious relief and development groups can play an important role in the response to HIV and AIDS in Central America, according to a new RAND Corporation report.

2 Jun 2010

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

VIVUS, Inc. today announced that data from the previously reported phase 3 pivotal REVIVE (TA-301) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED), were presented at the American Urological Association (AUA) 2010 Annual Meeting.

2 Jun 2010

Rep. Dingell opposes proposal for drug reimportation

Rep. John Dingell, D-Mich., will stand in the way of a proposal by Sen. Byron Dorgan, D-N.D., to attach a drug reimportation amendment to Dingell's food safety bill, which Dingell said "could derail the whole food safety effort," The Hill reports. "Adding to the charged politics is the widespread assumption that the Obama administration, which has made food safety a priority, may intervene behind the scenes against the amendment.

2 Jun 2010

Two-day Africa-France business relations summit begins, food security, fighting poverty will be discussed

The 25th Africa-France Summit, a two-day gathering "aimed at developing better business relations between" the regions, began Monday in the French city of Nice, All Headline News reports.

2 Jun 2010

FDA grants priority review status to Eisai's eribulin NDA

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted priority review status to the company's New Drug Application (NDA) for the investigational agent eribulin mesylate ("eribulin," also known as E7389). Eisai is seeking FDA approval for eribulin in the treatment of patients with locally advanced or metastatic breast cancer previously treated with at least two chemotherapy regimens, including an anthracycline and a taxane.

2 Jun 2010

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.

2 Jun 2010

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Only about one in three young women has received the human papillomavirus vaccine to help prevent cervical cancer, according to a new report from researchers at Washington University School of Medicine in St. Louis.

2 Jun 2010

Cancer patients should find ways to be physically active during and after treatment: New national guidelines

Cancer patients who've been told to rest and avoid exercise can - and should - find ways to be physically active both during and after treatment, according to new national guidelines. Kathryn Schmitz, PhD, MPH, an associate professor of Epidemiology and Biostatistics and a member of the Abramson Cancer Center at the University of Pennsylvania School of Medicine, will present these guidelines at an educational session at the 2010 meeting of the American Society of Clinical Oncology, aimed at making cancer exercise rehabilitation programs as common as those offered to people who have had heart attacks or undergone cardiac surgery.

2 Jun 2010

FDA accepts Orexigen's Contrave NDA for treatment of obesity

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity.

2 Jun 2010

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.

2 Jun 2010

FDA approves Prolia for postmenopausal women with osteoporosis

The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.

2 Jun 2010

Study results show calcium consumption increases prostate cancer risk in Chinese

Among Chinese men, calcium consumption — even at relatively low levels and from non-dairy food sources such as soy, grains and green vegetables — may increase prostate cancer risk, according to results published in Cancer Research, a journal of the American Association for Cancer Research.

2 Jun 2010

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin.

2 Jun 2010

Food News and Research

Bangalore INDIA BIO 2010 inaugurated

Perrigo acquires rights to Novel Laboratories' pending ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep Kit

Biomoda, Obio sign MOU to establish CLIA-certified clinical laboratory in Ohio

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

CookShop nutrition education program helps students make healthier food choices: Survey

Neuro Kinetics renews independent sales representation relationship with Kwangwoo Medix

Health Canada releases survey results of BPA exposure levels in canned foods

Faith-based organizations can play important role in response to HIV/AIDS in Central America: RAND study

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

Rep. Dingell opposes proposal for drug reimportation

Two-day Africa-France business relations summit begins, food security, fighting poverty will be discussed

FDA grants priority review status to Eisai's eribulin NDA

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Cancer patients should find ways to be physically active during and after treatment: New national guidelines

FDA accepts Orexigen's Contrave NDA for treatment of obesity

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

FDA approves Prolia for postmenopausal women with osteoporosis

Study results show calcium consumption increases prostate cancer risk in Chinese

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News